Clinical Trials Directory

Trials / Terminated

TerminatedNCT05555004

Evaluation of Probiotic (L.Reuteri) Survival in Presence of Prebiotic Galacto-oligosaccharides

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
24 Months – 36 Months
Healthy volunteers
Accepted

Summary

This research study will compare the effect of test product #1 (containing a probiotic with the Galacto-OligoSaccharides fiber. GOS) and test product #2 (containing a probiotic without the GOS fiber) to understand how they can contribute to healthy digestion in toddlers between the age of 24 - 36 months. The hypothesis is that L. reuteri from TEST#1 will demonstrate an improved survival in the GIT of toddlers compared to that of TEST#2. This study is a single-centre, randomized, double-blind, comparator-controlled, parallel group study. The study will be conducted at the Clinical Innovation Lab (CIL) at Nestlé Research.

Conditions

Interventions

TypeNameDescription
OTHERTEST1Toddler milk with preconditioned L. reuteri and containing GOS
OTHERTEST 2Toddler milk with standard/non-preconditioned L. reuteri and not containing GOS.

Timeline

Start date
2022-06-30
Primary completion
2023-04-06
Completion
2023-04-06
First posted
2022-09-26
Last updated
2023-05-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05555004. Inclusion in this directory is not an endorsement.

Evaluation of Probiotic (L.Reuteri) Survival in Presence of Prebiotic Galacto-oligosaccharides (NCT05555004) · Clinical Trials Directory